PDL BioPharma Inc. | Balance Sheet
Fiscal year is January-December. All values USD Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
100
294
220
242
532
395
Total Accounts Receivable
-
58
58
151
85
87
Other Current Assets
8
4
4
2
14
16
Total Current Assets
108
356
283
398
640
517
Net Property, Plant & Equipment
-
-
-
-
7
7
Total Investments and Advances
-
-
-
-
7
-
Long-Term Note Receivable
194
306
307
160
17
1
Intangible Assets
236
259
399
631
565
428
Total Assets
544
962
1,012
1,215
1,243
964
ST Debt & Current Portion LT Debt
395
175
25
-
126
Accounts Payable
-
-
-
7
20
Income Tax Payable
-
3
3
5
1
Other Current Liabilities
12
9
8
119
46
Total Current Liabilities
407
188
37
130
193
Long-Term Debt
-
276
229
232
117
Provision for Risks & Charges
-
-
38
84
31
Deferred Taxes
7
34
16
19
1
Other Liabilities
23
38
12
13
55
Total Liabilities
430
502
316
460
397
Common Equity (Total)
113
460
696
751
846
Total Shareholders' Equity
113
460
696
751
846
Total Equity
113
460
696
755
846
Liabilities & Shareholders' Equity
544
962
1,012
1,215
1,243
Accumulated Minority Interest
-
-
-
4
-
About PDL BioPharma
View Profile
